home > events calendar > more about event

Event profile: PHARMAPACK 2020


6-7 February 2020

Nemera will join more than 5,000 senior pharma professionals at Pharmapack, which will take place in Paris, on 5-6 February 2020.

Meet Nemera at the booth C56 to discover its innovative drug delivery devices and its end-to-end development offerings!

Our products:

Novelia®: our multidose eyedropper for preservative-free formulations. With Novelia®, 0% preservatives, 100% eye protection!

Safe’n’Sound®: our platform of fully passive safety devices for prefilled syringes to aid in the protection from accidental needlestick.

Safelia®: our new generation of 2-step autoinjectors for fluid or highly viscous formulations in 1ml and 2,25ml formats.

Advancia®: our new user-independent pump technology for nasal sprays.

SP270+: our high-performance and cost-effective pump for pharmaceutical sprays.

• New child-resistant spray system for oral and nasal sprays in collaboration with Roy LeClair.

Sof’Bag®: our high performing airless pouch system for dermal and transdermal applications.

Sof’Airless XS: our dermal package solutions suitable for liquid and viscous formulations in a comprehensive range of doses.

Nemera’s innovation department leverages multi-skilled teams to develop tailored electronic products and services across multiple device platforms. Our electronic concept devices showcase several features to make patients’ life easier such as delivery assistance, live feedback and adherence aid to their treatments:

e-Novelia®: the electronic add-on to combine with our multidose eyedropper Novelia® for enhanced patient experience.

e-Advancia®: the combination between our high performance pump Advancia® and a reusable electronic add-on to improve patient compliance.

Safe’n’Spray: the smart electronic concept device with locking features to monitor drug delivered and prevent overdosing.

Wearable concept: the smart injection device with a reusable and a disposable part

eNemera CS: the cloud solution to store and share data generated by Nemera’s electronic devices

This year, one of Nemera’s products will be featured in the Innovation Gallery and will be presented during the Innovation Tour.

The product is Safe’n’Spray, the integrated device with reusable electronic locking unit and fingerprint identification, to monitor drug delivered and prevent overdosing.

End-to-end development offerings

The Insight Innovation Center know-how allow to provide services spanning the full development lifecycle from front-end innovation (design research, human factors and design engineering) to strong late-stage development (pilot and industrialization, small and large scale GMP manufacturing). These newly enhanced capabilities enable Nemera to now offer complete end-to-end development services to all its customers globally and to collaborate with them earlier, supporting their complex drug delivery and medical device projects.

About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generics industries. Nemera offers a comprehensive portfolio of products and services across ophthalmology, nasal, inhalation, dermal, transdermal and parenteral delivery. Nemera’s vision is to be the most patient-centric drug delivery device company. Nemera always puts patients first, providing high-quality solutions that have a demonstrable impact on patients’ health.

For more information, please visit
If you want to contact us:
phone +33 4 74 94 06 54
email 20 avenue de la Gare, 38290 – La Verpilličre, France
Print this page
Send to a friend
Industry Events

Outsourcing in Clinical Trials Europe

6-7 May 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter – MMCTs)
More info >>

News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement